Food as a Medicine Market to Reach US$11.51 Billion by 2031, Driven by Chronic-Disease Nutrition Innovation | DataM Intelligence
Comunicato Precedente
Comunicato Successivo
Download PDF Brochure: https://www.datamintelligence.com/download-sample/food-as-a-medicine-market?KailasPRN
Browse in-depth TOC on "Food as a Medicine Market"
70 – Tables
66 – Figures
195 – Pages
Segmentation Analysis
By Product Type
The market covers several product categories: Dietary Supplements, Functional Foods & Beverages, Medical Foods, and Whole Foods & Natural Foods.
By Form
Within these product types, the form of delivery is segmented into Capsules, Tablets, Powders, Liquids, and Bars.
By Application
Applications for FAM products span a wide range of clinical and wellness needs: Cardiovascular, Anti-Aging, Detoxification, Nutritional Deficiency, Diabetes, Anti-Cancer, and Others.
Request for Customized Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/food-as-a-medicine-market?KailasPRN
By Distribution Channel
Distribution is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, and Supermarkets.
Competitive Landscape
The Food as a Medicine market features a mix of established nutrition-and-health companies and specialized medical-nutrition providers. According to DataM Intelligence, key players include Bionova, Nestlé, Primus Pharmaceuticals Inc., Season Health, Mead Johnson & Company, LLC, SFI Health, Metagenics, Meiji Holdings Co., Ltd., Bitewell, and Mealogic, among others.
Highlights:
Market Outlook & Strategic Opportunities
The Food as a Medicine market offers significant strategic opportunities:
Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=food-as-a-medicine-market
Conclusion
The global Food as a Medicine Market is entering a new phase of growth, transforming how nutrition is perceived and delivered-from a support function to a therapeutic modality. With the market projected to more than double from US$4.71 billion in 2023 to US$11.51 billion by 2031, at a sustained 12.2% CAGR, the landscape is set for innovation across product types, formats, applications, and channels. According to DataM Intelligence, companies that can bridge the gap between food, medicine, and consumer experience, leveraging clinical evidence, delivery infrastructure, and digital innovation, will lead this evolving market.
Related Report:
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn, and Facebook.
Contact:
Sai Kiran
DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/food-as-a-medicine-market-to-reach-us11-51-billion-by-2031--driven-by-chronic-disease-nutrition-innovation--datam-intelligence-302617165.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
